Stocks and Investing
Stocks and Investing
Wed, February 7, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Catherine Schulte Maintained (TECH) at Buy and Held Target at $39 on, Feb 7th, 2018
Catherine Schulte of Baird, Maintained "Bio-Techne Corporation" (TECH) at Buy and Held Target at $39 on, Feb 7th, 2018.
Catherine has made no other calls on TECH in the last 4 months.
There is 1 other peer that has a rating on TECH. Out of the 1 peers that are also analyzing TECH, 0 agree with Catherine's Rating of Hold.
This is the rating of the analyst that currently disagrees with Catherine
- Daniel Arias of "Citigroup" Maintained at Strong Buy with Increased Target to $36 on, Tuesday, October 24th, 2017